(Total Views: 604)
Posted On: 05/19/2020 10:32:55 PM
Post# of 72440
Thought I would post the following, the results will be the key to the future of POC, Brilacidin and it's success against the Covid19 pandemic and to our near term, expectations for share holders success:
" Testing Brilacidin’s direct virucidal activity on SARS-CoV-2 in human lung epithelial cells (by preincubating the novel coronavirus with Brilacidin at varying concentrations and times of incubation);
Obtaining the in vitro concentration of Brilacidin that gives half-maximal response, the EC50 value, in lung epithelial cells;
Determining impact of multiple dose exposure of Brilacidin on SARS-CoV-2 (assessing potential for achieving greater virus control without inducing toxicity);
Evaluating time-to-treatment windows as a post-exposure therapeutic (by introducing Brilacidin at 4, 8, and 16 hours post-initial infection, with virus cultures carried forward up to 48 hours);
Exploring if Brilacidin has synergistic properties with other small molecules That have antiviral activity".
All testing should be completed, now awaiting next "BIG" thing, PR announcing Results. Good luck to us!!! Next phase, Human testing.
" Testing Brilacidin’s direct virucidal activity on SARS-CoV-2 in human lung epithelial cells (by preincubating the novel coronavirus with Brilacidin at varying concentrations and times of incubation);
Obtaining the in vitro concentration of Brilacidin that gives half-maximal response, the EC50 value, in lung epithelial cells;
Determining impact of multiple dose exposure of Brilacidin on SARS-CoV-2 (assessing potential for achieving greater virus control without inducing toxicity);
Evaluating time-to-treatment windows as a post-exposure therapeutic (by introducing Brilacidin at 4, 8, and 16 hours post-initial infection, with virus cultures carried forward up to 48 hours);
Exploring if Brilacidin has synergistic properties with other small molecules That have antiviral activity".
All testing should be completed, now awaiting next "BIG" thing, PR announcing Results. Good luck to us!!! Next phase, Human testing.
(2)
(1)Scroll down for more posts ▼
